TDF抗病毒治療乙肝肝硬化代償期合并糖尿病的效果及安全性分析

打開文本圖片集

【摘要】目的：探討在乙肝肝硬化代償期合并DM治療中，TDF抗病毒治療的臨床效果與安全性。方法：選取我院接診的乙肝肝硬化代償期合并DM患者30例，分為對照組與觀察組，分別給予恩替卡韋與TDF，對比兩組患者治療前后血糖、肝功能指標變化以及臨床效果與安全性。結(jié)果：治療后，觀察組血糖指標FPG低于對照組，肝功能指標ALT、TBIL、ALB檢測結(jié)果低于對照組，總有效率為100.00%高于對照組，差異均有統(tǒng)計學意義（P

【關(guān)鍵詞】富馬酸替諾福韋酯；乙肝肝硬化代償期；糖尿病

Efficacy and safety of TDF antiviral therapy for compensatory hepatitis B cirrhosis complicated with diabetes mellitus

ZHU Yongfeng

Department of Infectious Diseases， Dezhou Second People’s Hospital， Shandong， Dezhou， Shandong 253004， China

【Abstract】Objective：To investigate the clinical effect and safety of TDF antiviral therapy in the compensatory stage of hepatitis B cirrhosis complicated with DM.Methods：30 patients with hepatitis B cirrhosis in the compensatory stage complicated with DM received in our hospital were divided into the control group and the observation group.They were given entecavir and TDF respectively，and the changes of blood glucose，liver function indexes，clinical effects and safety of the two groups were compared before and after treatment. Results：After treatment，the blood glucose index FPG in the observation group was lower than that in the control group，the detection results of liver function indexes ALT，TBIL，ALB were lower than those in the control group，and the total effective rate was 100.00% higher than that in the control group，the differences were statistically significant（P

【Key？Words】Tenofovir disoproxil fumarate； Compensatory stage of hepatitis B cirrhosis； Diabetes

乙肝肝炎病毒（HBV）感染是威脅人們生命安全的世界性難題，全球每年因乙肝以及相關(guān)疾病導致死亡的很多。（剩余3770字）